• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉造影术后血清激活素 A 水平与肾脏结局。

Serum Activin A Levels and Renal Outcomes After Coronary Angiography.

机构信息

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.

出版信息

Sci Rep. 2020 Feb 25;10(1):3365. doi: 10.1038/s41598-020-60359-x.

DOI:10.1038/s41598-020-60359-x
PMID:32099067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7042345/
Abstract

Prevention for contrast-induced nephropathy (CIN) is limited by the lack of a single predictor. As activin A is upregulated in heart failure and chronic kidney disease, we aimed to clarify the association between activin A levels and renal outcomes after coronary angiography (CAG). This prospective observational study included 267 patients who received CAG between 2009 and 2015. CIN was defined as elevation of serum creatinine to >0.5 mg/dL or to >25% above baseline within 48 hours after CAG. During follow-up, laboratory parameters were measured every 3-6 months. Renal decline was defined as>2-fold increase in serum creatinine or initiation of dialysis. The patients were stratified into tertiles according to serum activin A levels at baseline. High activin A tertile was significantly associated more CIN and renal function decline compared to low activin A tertile (all p < 0.001). After adjusting potential confounding factors, high serum activin A tertiles was associated to CIN (Odds ratio 4.49, 95% CI 1.07-18.86, p = 0.040) and renal function decline (Hazard ratio 4.49, 95% CI 1.27-11.41, p = 0.017) after CAG.

摘要

对比剂诱导肾病(CIN)的预防受到缺乏单一预测因子的限制。由于激活素 A 在心力衰竭和慢性肾脏病中上调,我们旨在阐明激活素 A 水平与冠状动脉造影(CAG)后肾脏结局之间的关系。这项前瞻性观察性研究纳入了 2009 年至 2015 年间接受 CAG 的 267 名患者。CIN 的定义为 CAG 后 48 小时内血清肌酐升高至>0.5mg/dL 或比基线升高>25%。在随访期间,每 3-6 个月测量实验室参数。肾功能下降定义为血清肌酐升高>2 倍或开始透析。根据基线时的血清激活素 A 水平,患者被分为三分位。与低激活素 A 三分位相比,高激活素 A 三分位与更多的 CIN 和肾功能下降显著相关(均 p<0.001)。在调整潜在混杂因素后,高血清激活素 A 三分位与 CIN(优势比 4.49,95%置信区间 1.07-18.86,p=0.040)和 CAG 后肾功能下降(危险比 4.49,95%置信区间 1.27-11.41,p=0.017)相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/0e4527bf91c9/41598_2020_60359_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/10b1e060740e/41598_2020_60359_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/f8c36ea256fa/41598_2020_60359_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/3f6659003833/41598_2020_60359_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/0e4527bf91c9/41598_2020_60359_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/10b1e060740e/41598_2020_60359_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/f8c36ea256fa/41598_2020_60359_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/3f6659003833/41598_2020_60359_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/7042345/0e4527bf91c9/41598_2020_60359_Fig4_HTML.jpg

相似文献

1
Serum Activin A Levels and Renal Outcomes After Coronary Angiography.冠状动脉造影术后血清激活素 A 水平与肾脏结局。
Sci Rep. 2020 Feb 25;10(1):3365. doi: 10.1038/s41598-020-60359-x.
2
Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography.循环半乳糖凝集素-1 水平升高与接受冠状动脉造影检查的患者肾功能下降的进展相关。
Sci Rep. 2020 Jan 29;10(1):1435. doi: 10.1038/s41598-020-58132-1.
3
Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.抗坏血酸预防慢性肾功能损害患者冠状动脉造影后对比剂肾病:一项随机对照试验
Ther Apher Dial. 2013 Aug;17(4):384-90. doi: 10.1111/1744-9987.12083.
4
Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.伴有和不伴有慢性肾脏病的ST段抬高型心肌梗死患者的对比剂肾病
Crit Pathw Cardiol. 2018 Mar;17(1):25-31. doi: 10.1097/HPC.0000000000000123.
5
Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.血清肌酐比值:肾功能正常和异常患者经皮冠状动脉介入治疗后死亡率的新型预测指标。
Catheter Cardiovasc Interv. 2009 Jul 1;74(1):49-55. doi: 10.1002/ccd.21946.
6
The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.在慢性肾脏病患者中,血管紧张素受体阻滞剂与钙通道阻滞剂联合应用对造影剂肾病没有益处。
Ren Fail. 2013;35(4):434-9. doi: 10.3109/0886022X.2013.766566. Epub 2013 Feb 18.
7
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.茶碱对慢性肾功能不全患者冠状动脉造影后肾功能损害的预防效果。
Am J Cardiol. 2003 May 15;91(10):1157-62. doi: 10.1016/s0002-9149(03)00259-5.
8
Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.血清渗透压作为择期冠状动脉造影后对比剂肾病的潜在预测因子。
Int Urol Nephrol. 2020 Mar;52(3):541-547. doi: 10.1007/s11255-020-02391-4. Epub 2020 Feb 1.
9
Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中γ-谷氨酰转移酶水平对造影剂诱导的肾病的预测价值
Am J Cardiol. 2015 Sep 1;116(5):711-6. doi: 10.1016/j.amjcard.2015.05.042. Epub 2015 Jun 4.
10
The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration.冠状动脉造影术中同步血液滤过预防造影剂肾病:与围手术期血液滤过的比较。
Int J Cardiol. 2014 Oct 20;176(3):941-5. doi: 10.1016/j.ijcard.2014.08.095. Epub 2014 Aug 23.

引用本文的文献

1
Myostatin and Activin A as Biomarkers of Sarcopenia in Inflammatory Bowel Disease Patients.肌抑素和激活素 A 作为炎症性肠病患者肌少症的生物标志物。
Nutrients. 2024 Mar 12;16(6):810. doi: 10.3390/nu16060810.

本文引用的文献

1
The Prevention and Management of Contrast-induced Acute Kidney Injury: A Mini-review of the Literature.对比剂诱导的急性肾损伤的预防与管理:文献综述
Cureus. 2018 Sep 11;10(9):e3284. doi: 10.7759/cureus.3284.
2
Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography.循环成纤维细胞生长因子 21 与行冠状动脉造影患者的后续肾脏损伤事件相关。
Sci Rep. 2018 Aug 20;8(1):12425. doi: 10.1038/s41598-018-30744-8.
3
Activin receptor ligand traps in chronic kidney disease.
慢性肾脏病中的激活素受体配体陷阱。
Curr Opin Nephrol Hypertens. 2018 Sep;27(5):351-357. doi: 10.1097/MNH.0000000000000433.
4
Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.鉴定尿激活素 A 作为反映急性肾损伤严重程度的新型生物标志物。
Sci Rep. 2018 Mar 26;8(1):5176. doi: 10.1038/s41598-018-23564-3.
5
The Association Between Serum Activin A Levels and Hypertension in the Elderly: A Cross-Sectional Analysis From I-Lan Longitudinal Aging Study.血清激活素 A 水平与老年人高血压的相关性:一项来自宜兰纵向老龄化研究的横断面分析。
Am J Hypertens. 2018 Feb 9;31(3):369-374. doi: 10.1093/ajh/hpx185.
6
Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention.短暂性或持续性造影剂诱发的肾病对择期经皮冠状动脉介入治疗后长期死亡率的影响。
Am J Cardiol. 2017 Dec 15;120(12):2146-2153. doi: 10.1016/j.amjcard.2017.08.036. Epub 2017 Sep 19.
7
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.在慢性肾脏病期间,激活素受体在骨骼、血管、心脏和肾脏中被刺激。
Kidney Int. 2018 Jan;93(1):147-158. doi: 10.1016/j.kint.2017.06.016. Epub 2017 Aug 23.
8
Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.IIA型激活素受体的配体陷阱可抑制慢性肾病糖尿病小鼠中破骨细胞对骨重塑的刺激作用。
Kidney Int. 2017 Jan;91(1):86-95. doi: 10.1016/j.kint.2016.07.039. Epub 2016 Sep 22.
9
Heart failure and kidney dysfunction: epidemiology, mechanisms and management.心力衰竭与肾脏功能障碍:流行病学、发病机制与治疗。
Nat Rev Nephrol. 2016 Oct;12(10):610-23. doi: 10.1038/nrneph.2016.113. Epub 2016 Aug 30.
10
Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.激活素IIA型受体的配体陷阱可预防慢性肾病小鼠的血管疾病和肾纤维化。
Kidney Int. 2016 Jun;89(6):1231-43. doi: 10.1016/j.kint.2016.02.002. Epub 2016 Mar 11.